Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply

Rheumatology (Oxford). 2019 Nov 1;58(11):2073-2074. doi: 10.1093/rheumatology/kez329.

Alexander Oldroyd^{1

2}, Jamie C Sergeant^{3

4}, R Paul New⁵, Neil J McHugh^{6

7}, Zoe Betteridge⁶, Janine A Lamb⁸, William E Ollier⁹, Robert G Cooper^{5

10}, Hector Chinoy^{1

2

11}

¹ Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
² NIHR Manchester Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
³ Centre for Biostatistics, Manchester, UK.
⁴ Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK.
⁵ MRC/ARUK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool, Liverpool, UK.
⁶ Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
⁷ Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Foundation Trust, Bath, UK.
⁸ Division of Population Health, Health Services Research and Primary Care, Manchester, UK.
⁹ Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK.
¹⁰ Department of Rheumatology, Aintree University Hospital, Liverpool, UK.
¹¹ Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK.

No abstract available

Publication types